Export 2732 results:
Author Title [ Type(Desc)] Year
Journal Article
S. EK, “Acute rejection probability and severity are declining after pediatric renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).”, 1998.
R. McDonald, Ho, P. L., Stablein, D. M., and Tejani, A., “Acute rejection rate, time to first rejection and rejection reversals comparing the 1987-1989 pediatric renal transplant recipient cohort to the 1997-1999 cohort. A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)”, 2000.
J. F. Bobb, Qiu, H., Matthews, A. G., McCormack, J., and Bradley, K. A., “Addressing identification bias in the design and analysis of cluster-randomized pragmatic trials: a case study.”, Trials, vol. 21, no. 1, p. 289, 2020.
S. DM, “Adequacy of care for children with chronic renal insufficiency: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)”, 1998.
T. D. Keenan, Agrón, E., Mares, J. A., Clemons, T. E., van Asten, F., Swaroop, A., and Chew, E. Y., “Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2.”, Alzheimers Dement, vol. 16, no. 6, pp. 831-842, 2020.
T. D. Keenan, Agrón, E., Mares, J., Clemons, T. E., van Asten, F., Swaroop, A., and Chew, E. Y., “Adherence to the Mediterranean Diet and Progression to Late Age-Related Macular Degeneration in the Age-Related Eye Disease Studies 1 and 2.”, Ophthalmology, 2020.
O. N, “Adjusting Moran’s I for population density,”, Stat Med, vol. 14, pp. 17-26, 1995.
N. Oden, “Adjusting Moran's I for population density.”, Stat Med, vol. 14, no. 1, pp. 17-26, 1995.
S. S. El-Kamary, Pasetti, M. F., Mendelman, P. M., Frey, S. E., Bernstein, D. I., Treanor, J. J., Ferreira, J., Chen, W. H., Sublett, R., Richardson, C., Bargatze, R. F., Sztein, M. B., and Tacket, C. O., “Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues.”, J Infect Dis, vol. 202, no. 11, pp. 1649-58, 2010.
S. El-Kamary, Pasetti, M., Mendelman, P., Frey, S., Bernstein, D., Treanor, J., Ferreira, J., Chen, W., Sublett, R., Richardson, C., Bargatze, R., Sztein, M., and Tacket, C., “Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues”, J Infect Dis, vol. 202, pp. 1648-1658, 2010.
“The advanced glaucoma intervention study, 6: effect of cataract on visual field and visual acuity. The AGIS Investigators.”, Arch Ophthalmol, vol. 118, no. 12, pp. 1639-52, 2000.
“The Advanced Glaucoma Intervention Study: 8. Risk of cataract formation after trabeculectomy.”, Arch Ophthalmol, vol. 119, no. 12, pp. 1771-9, 2001.
D. E. Gaasterland, Blackwell, B., Dally, L. G., Caprioli, J., Katz, L. J., Ederer, F., and Investigators, A. G. I. S., “The Advanced Glaucoma Intervention Study (AGIS) 10: Variability among academic glaucoma subspecialists in assessing optic disc notching”, Trans Am Ophthalmol, vol. 99, pp. 177-85, 2001.
“The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty.”, Am J Ophthalmol, vol. 134, no. 4, pp. 481-98, 2002.
A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty”, Am J Ophthalmol, vol. 134, pp. 481-498, 2002.
A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma”, Am J Ophthalmol, vol. 134, pp. 499-512, 2002.
“The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma.”, Am J Ophthalmol, vol. 134, no. 4, pp. 499-512, 2002.
F. Ederer, Gaasterland, D. A., Dally, L. G., Kim, J., VanVeldhuisen, P. C., Blackwell, B., Prum, B., Shafranov, G., Allen, R. C., and Beck, A., “The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results.”, Ophthalmology, vol. 111, no. 4, pp. 651-64, 2004.
A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race. Ten-year results”, Ophthalmology, vol. 111, pp. 651-664, 2004.
J. Kim, Dally, L., Ederer, F., Gaasterland, D., Van Veldhuisen, P., Blackwell, B., Sullivan, E., Prum, B., Shafranov, G., Beck, A., Spaeth, G., and Investigators, A. G. I. S., “The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing Progression of Glaucoma from Visual Field Fluctuations”, Ophthalmology, vol. 111, pp. 2109-2116, 2004.
J. Kim, Dally, L. G., Ederer, F., Gaasterland, D. E., VanVeldhuisen, P. C., Blackwell, B., E Sullivan, K., Prum, B., Shafranov, G., Beck, A., and Spaeth, G. L., “The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing progression of glaucoma from visual field fluctuations.”, Ophthalmology, vol. 111, no. 11, pp. 2109-16, 2004.
T. A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 3. Baseline characteristics of black and white patients”, Ophthalmology, vol. 105, pp. 1137-45, 1998.
“The Advanced Glaucoma Intervention Study (AGIS): 3. Baseline characteristics of black and white patients.”, Ophthalmology, vol. 105, no. 7, pp. 1137-45, 1998.
T. A. G. I. S. Investigators, “The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven year results”, Ophthalmology, vol. 105, pp. 1146-64, 1998.
“The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race. Seven-year results.”, Ophthalmology, vol. 105, no. 7, pp. 1146-64, 1998.